Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Stromal Cell Signature Associated with Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.

Katayama MLH, Vieira RADC, Andrade VP, Roela RA, Lima LGCA, Kerr LM, Campos AP, Pereira CAB, Serio PAMP, Encinas G, Maistro S, Petroni MAL, Brentani MM, Folgueira MAAK.

Cells. 2019 Dec 4;8(12). pii: E1566. doi: 10.3390/cells8121566.

2.

Transcriptomic Response to 1,25-Dihydroxyvitamin D in Human Fibroblasts with or without a Functional Vitamin D Receptor (VDR): Novel Target Genes and Insights into VDR Basal Transcriptional Activity.

Costa PLF, França MM, Katayama ML, Carneiro ET, Martin RM, Folgueira MAK, Latronico AC, Ferraz-de-Souza B.

Cells. 2019 Apr 5;8(4). pii: E318. doi: 10.3390/cells8040318.

3.

Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil.

Guindalini RSC, Cormedi MCV, Maistro S, Pasini FS, Branas PCAA, Dos Santos L, de Lima Pereira GF, de Bock GH, Saccaro DM, Katayama MLH, Faraj SF, Safatle-Ribeiro A, Ribeiro Junior U, Diz MDPE, de Gouvêa ACRC, Chammas R, Folgueira MAAK.

Gastric Cancer. 2019 Sep;22(5):920-931. doi: 10.1007/s10120-019-00945-9. Epub 2019 Mar 20.

4.

Survival and prognosis of young adults with gastric cancer.

Cormedi MCV, Katayama MLH, Guindalini RSC, Faraj SF, Folgueira MAAK.

Clinics (Sao Paulo). 2018 Sep 21;73(suppl 1):e651s. doi: 10.6061/clinics/2018/e651s.

5.

Orthotopic tumorgrafts in nude mice as a model to evaluate calcitriol effects in breast cancer.

Fonseca-Filho VCN, Katayama MLH, Lyra EC, Maria DA, Basso RA, Nonogaki S, Guerra JM, Maistro S, Góes JCGS, Folgueira MAAK.

Braz J Biol. 2017 Nov;77(4):856-867. doi: 10.1590/1519-6984.04016. Epub 2017 May 4.

6.

Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil.

Maistro S, Teixeira N, Encinas G, Katayama ML, Niewiadonski VD, Cabral LG, Ribeiro RM, Gaburo Junior N, de Gouvêa AC, Carraro DM, Sabino EC, Diz MD, Chammas R, de Bock GH, Folgueira MA.

BMC Cancer. 2016 Dec 3;16(1):934.

7.

Somatic mutations in breast and serous ovarian cancer young patients: a systematic review and meta-analysis.

Encinas G, Maistro S, Pasini FS, Katayama ML, Brentani MM, Bock GH, Folgueira MA.

Rev Assoc Med Bras (1992). 2015 Sep-Oct;61(5):474-83. doi: 10.1590/1806-9282.61.05.474. Review.

8.

Specific upregulation of RHOA and RAC1 in cancer-associated fibroblasts found at primary tumor and lymph node metastatic sites in breast cancer.

Rozenchan PB, Pasini FS, Roela RA, Katayama ML, Mundim FG, Brentani H, Lyra EC, Brentani MM.

Tumour Biol. 2015 Dec;36(12):9589-97. doi: 10.1007/s13277-015-3727-1. Epub 2015 Jul 5.

PMID:
26142737
9.

Transcriptional profile of fibroblasts obtained from the primary site, lymph node and bone marrow of breast cancer patients.

Del Valle PR, Milani C, Brentani MM, Katayama ML, de Lyra EC, Carraro DM, Brentani H, Puga R, Lima LA, Rozenchan PB, Nunes Bdos S, Góes JC, Azevedo Koike Folgueira MA.

Genet Mol Biol. 2014 Sep;37(3):480-9.

10.

Estrogen-responsive genes overlap with triiodothyronine-responsive genes in a breast carcinoma cell line.

Figueiredo NB, Cestari SH, Conde SJ, Luvizotto RA, De Sibio MT, Perone D, Katayama ML, Carraro DM, Brentani HP, Brentani MM, Nogueira CR.

ScientificWorldJournal. 2014 Jan 23;2014:969404. doi: 10.1155/2014/969404. eCollection 2014.

11.

Markers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: a systematic review including our case series.

Folgueira MA, Maistro S, Katayama ML, Roela RA, Mundim FG, Nanogaki S, de Bock GH, Brentani MM.

Biosci Rep. 2013 Dec 12;33(6). pii: e00085. doi: 10.1042/BSR20130060. Review.

12.

Breast cancer tissue slices as a model for evaluation of response to rapamycin.

Grosso SH, Katayama ML, Roela RA, Nonogaki S, Soares FA, Brentani H, Lima L, Folgueira MA, Waitzberg AF, Pasini FS, Góes JC, Brentani MM.

Cell Tissue Res. 2013 Jun;352(3):671-84. doi: 10.1007/s00441-013-1608-8. Epub 2013 May 1.

PMID:
23636418
13.

Calcitriol supplementation effects on Ki67 expression and transcriptional profile of breast cancer specimens from post-menopausal patients.

Urata YN, Lyra EC, Katayama ML, Basso RA, Assis PE, Cardoso AP, Roela RA, Nonogaki S, Sampaio Góes JC, Brentani MM, Folgueira MA.

Clin Nutr. 2014 Feb;33(1):136-42. doi: 10.1016/j.clnu.2013.04.001. Epub 2013 Apr 9.

PMID:
23623780
14.

Transcriptional effects of 1,25 dihydroxyvitamin D(3) physiological and supra-physiological concentrations in breast cancer organotypic culture.

Milani C, Katayama ML, de Lyra EC, Welsh J, Campos LT, Brentani MM, Maciel Mdo S, Roela RA, del Valle PR, Góes JC, Nonogaki S, Tamura RE, Folgueira MA.

BMC Cancer. 2013 Mar 15;13:119. doi: 10.1186/1471-2407-13-119.

15.

Differences in transcriptional effects of 1α,25 dihydroxyvitamin D3 on fibroblasts associated to breast carcinomas and from paired normal breast tissues.

Campos LT, Brentani H, Roela RA, Katayama ML, Lima L, Rolim CF, Milani C, Folgueira MA, Brentani MM.

J Steroid Biochem Mol Biol. 2013 Jan;133:12-24. doi: 10.1016/j.jsbmb.2012.08.002. Epub 2012 Aug 23.

16.

Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis.

Martin P, Teodoro WR, Velosa AP, de Morais J, Carrasco S, Christmann RB, Goldenstein-Schainberg C, Parra ER, Katayama ML, Sotto MN, Capelozzi VL, Yoshinari NH.

Autoimmun Rev. 2012 Sep;11(11):827-35. doi: 10.1016/j.autrev.2012.02.017. Epub 2012 Mar 2. Review.

PMID:
22406224
17.

Gene expression profile in response to doxorubicin-rapamycin combined treatment of HER-2-overexpressing human mammary epithelial cell lines.

Trapé AP, Katayama ML, Roela RA, Brentani H, Ravacci GR, de Araujo Lima L, Brentani MM.

Mol Cancer Ther. 2012 Feb;11(2):464-74. doi: 10.1158/1535-7163.MCT-11-0033. Epub 2011 Nov 14.

18.

Transcriptional profile and response to neoadjuvante chemotherapy in breast cancer.

Folgueira MA, Snitcovsky IM, Del Valle PR, Katayama ML, Brentani MM, Vieira RA.

Rev Assoc Med Bras (1992). 2011 May-Jun;57(3):347-52. Review. English, Portuguese.

19.

Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients.

Barros Filho MC, Katayama ML, Brentani H, Abreu AP, Barbosa EM, Oliveira CT, Góes JC, Brentani MM, Folgueira MA.

Braz J Med Biol Res. 2010 Dec;43(12):1225-31. Epub 2010 Nov 26.

20.

Influence of the interaction between nodal fibroblast and breast cancer cells on gene expression.

Santos RP, Benvenuti TT, Honda ST, Del Valle PR, Katayama ML, Brentani HP, Carraro DM, Rozenchan PB, Brentani MM, de Lyra EC, Torres CH, Salzgeber MB, Kaiano JH, Góes JC, Folgueira MA.

Tumour Biol. 2011 Feb;32(1):145-57. doi: 10.1007/s13277-010-0108-7. Epub 2010 Sep 6.

21.

Human breast tumor slices: a model for identification of vitamin D regulated genes in the tumor microenvironment.

Milani C, Welsh J, Katayama ML, Lyra EC, Maciel MS, Brentani MM, Folgueira MA.

J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):151-5. doi: 10.1016/j.jsbmb.2010.03.051. Epub 2010 Mar 20.

PMID:
20307664
22.

Collagen V-induced nasal tolerance downregulates pulmonary collagen mRNA gene and TGF-beta expression in experimental systemic sclerosis.

Velosa AP, Teodoro WR, dos Anjos DM, Konno R, Oliveira CC, Katayama ML, Parra ER, Capelozzi VL, Yoshinari NH.

Respir Res. 2010 Jan 4;11:1. doi: 10.1186/1465-9921-11-1.

23.

Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis.

Parra ER, Teodoro WR, de Morais J, Katayama ML, de Souza R, Yoshinari NH, Capelozzi VL.

Eur J Clin Invest. 2010 Feb;40(2):110-20. doi: 10.1111/j.1365-2362.2009.02224.x. Epub 2009 Nov 24.

PMID:
19968698
24.

Influence of estradiol and triiodothyronine on breast cancer cell lines proliferation and expression of estrogen and thyroid hormone receptors.

Cestari SH, Figueiredo NB, Conde SJ, Clara S, Katayama ML, Padovani CR, Brentani MM, Nogueira CR.

Arq Bras Endocrinol Metabol. 2009 Oct;53(7):859-64.

PMID:
19942988
25.

Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas.

Makdissi FB, Machado LV, Oliveira AG, Benvenuti TT, Katayama ML, Brentani MM, Osório CA, Mourão Netto M, Lyra EC, Carvalho F, Góes JC, Folgueira MA.

Braz J Med Biol Res. 2009 Dec;42(12):1128-37. Epub 2009 Nov 6.

26.

Reciprocal changes in gene expression profiles of cocultured breast epithelial cells and primary fibroblasts.

Rozenchan PB, Carraro DM, Brentani H, de Carvalho Mota LD, Bastos EP, e Ferreira EN, Torres CH, Katayama ML, Roela RA, Lyra EC, Soares FA, Folgueira MA, Góes JC, Brentani MM.

Int J Cancer. 2009 Dec 15;125(12):2767-77. doi: 10.1002/ijc.24646.

27.

Tamoxifen inhibits transforming growth factor-alpha gene expression in human breast carcinoma samples treated with triiodothyronine.

Conde SJ, Luvizotto RA, Síbio MT, Katayama ML, Brentani MM, Nogueira CR.

J Endocrinol Invest. 2008 Dec;31(12):1047-51.

PMID:
19246968
28.

Expression of heterochromatin protein 1 in the primary tumor of breast cancer patients in the presence or absence of occult metastatic cells in the bone marrow.

Abreu AP, Milani C, Katayama ML, Barbosa KC, Gomes da Fonseca L, Goes JC, Brentani MM, Koike Folgueira MA.

Int J Biol Markers. 2008 Oct-Dec;23(4):219-24.

PMID:
19199269
29.

Tumor slices as a model to evaluate doxorubicin in vitro treatment and expression of trios of genes PRSS11, MTSS1, CLPTM1 and PRSS11, MTSS1, SMYD2 in canine mammary gland cancer.

Sobral RA, Honda ST, Katayama ML, Brentani H, Brentani MM, Patrão DF, Folgueira MA.

Acta Vet Scand. 2008 Jul 4;50:27. doi: 10.1186/1751-0147-50-27.

30.

Gene expression profiling of clinical stages II and III breast cancer.

Folgueira MA, Brentani H, Katayama ML, Patrão DF, Carraro DM, Mourão Netto M, Barbosa EM, Caldeira JR, Abreu AP, Lyra EC, Kaiano JH, Mota LD, Campos AH, Maciel MS, Dellamano M, Caballero OL, Brentani MM.

Braz J Med Biol Res. 2006 Aug;39(8):1101-13.

31.

25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer.

de Lyra EC, da Silva IA, Katayama ML, Brentani MM, Nonogaki S, Góes JC, Folgueira MA.

J Steroid Biochem Mol Biol. 2006 Aug;100(4-5):184-92. Epub 2006 Jul 7.

PMID:
16828283
32.

Gene expression profile associated with response to doxorubicin-based therapy in breast cancer.

Folgueira MA, Carraro DM, Brentani H, Patrão DF, Barbosa EM, Netto MM, Caldeira JR, Katayama ML, Soares FA, Oliveira CT, Reis LF, Kaiano JH, Camargo LP, Vêncio RZ, Snitcovsky IM, Makdissi FB, e Silva PJ, Góes JC, Brentani MM.

Clin Cancer Res. 2005 Oct 15;11(20):7434-43.

33.

Ras activation is associated with vitamin D receptor mRNA instability in HC11 mammary cells.

Rozenchan PB, Folgueira MA, Katayama ML, Snitcovsky IM, Brentani MM.

J Steroid Biochem Mol Biol. 2004 Sep;92(1-2):89-95.

PMID:
15544934
34.

Normal HC11 and ras-transformed mouse mammary cells are resistant to the antiproliferative effects of retinoic acid.

Snitcovsky I, Katayama ML, Folgueira MA, Brentani MM.

Braz J Med Biol Res. 2003 Dec;36(12):1761-8. Epub 2003 Nov 17.

35.

Vitamin D3 modulation of plasminogen activator inhibitor type-1 in human breast carcinomas under organ culture.

Barbosa EM, Nonogaki S, Katayama ML, Folgueira MA, Alves VF, Brentani MM.

Virchows Arch. 2004 Feb;444(2):175-82. Epub 2003 Dec 2.

PMID:
14652754
36.

Simultaneous changes in the function and expression of beta 1 integrins during the growth arrest of poorly differentiated colorectal cells (LISP-1).

Roela RA, Brentani MM, Katayama ML, Reis M, Federico MH.

Braz J Med Biol Res. 2003 Aug;36(8):1091-9. Epub 2003 Jul 23.

37.

Molecular targets of 1,25(OH)2D3 in HC11 normal mouse mammary cell line.

Katayama ML, Pasini FS, Folgueira MA, Snitcovsky IM, Brentani MM.

J Steroid Biochem Mol Biol. 2003 Jan;84(1):57-69.

PMID:
12648525
38.

Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a mini review.

Bortman P, Folgueira MA, Katayama ML, Snitcovsky IM, Brentani MM.

Braz J Med Biol Res. 2002 Jan;35(1):1-9. Review.

39.

Human semaphorin 6B [(HSA)SEMA6B], a novel human class 6 semaphorin gene: alternative splicing and all-trans-retinoic acid-dependent downregulation in glioblastoma cell lines.

Correa RG, Sasahara RM, Bengtson MH, Katayama ML, Salim AC, Brentani MM, Sogayar MC, de Souza SJ, Simpson AJ.

Genomics. 2001 May 1;73(3):343-8.

PMID:
11350127
40.

Effects of retinoic and glycolic acids on neoangiogenesis and necrosis of axial dorsal skin flaps in rats.

Landecker A, Katayama ML, Mammana AK, Leitão RM, Sachetta T, Gemperli R, Neves RI.

Aesthetic Plast Surg. 2001 Mar-Apr;25(2):134-9.

PMID:
11349304
41.

Correction of Stahl's Ear.

Aki FE, Kaimoto CL, Katayama ML, Kamakura L, Ferreira MC.

Aesthetic Plast Surg. 2000 Sep-Oct;24(5):382-5.

PMID:
11084701
42.

Differential regulation of vitamin D receptor expression in distinct leukemic cell lines upon phorbol ester-induced growth arrest.

Folgueira MA, Federico MH, Roela RA, Maistro S, Katayama ML, Brentani MM.

Braz J Med Biol Res. 2000 May;33(5):559-68.

43.

Eosinophil accumulation in rat uterus following estradiol administration is modulated by laminin and its integrin receptors.

Katayama ML, Federico MH, Brentani RR, Brentani MM.

Cell Adhes Commun. 1998 Jul;5(5):409-24.

PMID:
9789687
44.
45.

Integrin receptors and TGF-beta expression in chronic myeloid leukemia cells.

Federico MH, Snitcovsky I, Maistro S, Katayama ML, Figueiredo VL, Brentani MM.

Braz J Med Biol Res. 1994 Sep;27(9):2267-71.

PMID:
7787810
46.

Differential expression of fibronectin receptors during myeloid differentiation and in marrow- and peripheral blood-derived leukemic cells.

Yamamoto M, Federico MH, Maria DA, Koike MA, Katayama ML, Roela RA, Sonohara S, Brentani MM.

Int J Hematol. 1993 Oct;58(3):169-76.

PMID:
8148494
47.

Glucocorticoid receptors in mononuclear cells of patients with sepsis.

Sigal GA, Maria DA, Katayama ML, Wajchenberg BL, Brentani MM.

Scand J Infect Dis. 1993;25(2):245-8.

PMID:
8511519
48.

Vitamin D3 binding activity during leukemic cell differentiation.

Feldman J, Federico MH, Sonohara S, Katayama ML, Koike MA, Roela RA, da Silva MR, Brentani MM.

Leuk Res. 1993 Jan;17(1):97-101.

PMID:
7679173
49.

Increased expression of laminin receptors during myeloid differentiation.

Federico MH, Maria DA, Sonohara S, Yamamoto M, Katayama ML, Brentani MM.

Int J Cancer. 1991 Aug 19;49(1):32-7.

PMID:
1831441
50.

Interaction of laminin and fibronectin with leukemic cells.

Brentani MM, Federico MH, Yamamoto M, Maria DA, Katayama ML, Sonohara S, Roela RA.

Mem Inst Oswaldo Cruz. 1991;86 Suppl 3:43-50. No abstract available.

Supplemental Content

Loading ...
Support Center